How effective is DELIVRA?
• LivRelief’s Retrospective Clinical Trial shows a range of 57% to 75% reduction in pain from consistent cream use. • LivRelief’s Double-Blind Placebo Joint Study shows patients’ pain reduced by 44%, mobility increased by 65% and quality of life increased by 59%. • A Clinical Trial of a transdermal skin test shows that DELIVRA, after 24 hours, was 687% more effective than its main competitor. • The Compound Base Clinical Trial shows a 50% to 75% reduction in drugs that are inserted into the cream base, resulting in cost savings for pharmacies and a lower concentration of drugs absorbed by the skin, resulting in fewer side effects from the active ingredients.
